Lululemon Athletica

Chip Wilson is the dominant decision-maker across the family's investment vehicles. He operates through entities like Hold It All for major public/private consumer stakes, and he and his wife Summer have directed their real estate acquisitions personally. There is no publicly known investment committee structure; the architecture is founder- and family-led.

Wilson founded Lululemon Athletica in 1998 and served as its chief executive and board chairman before stepping down in 2013. His family fortune was built almost entirely through his founding equity stake in the company. While he no longer holds an executive role, he has remained a significant shareholder and periodically engages with company strategy through public letters and media appearances.

The line is deliberately blurred. Wilson's $100 million commitment to Solve FSHD functions like a biotech venture portfolio, backing early-stage companies such as Vita Therapeutics and Fulcrum Therapeutics in pursuit of a cure for muscular dystrophy. This sits alongside a traditional but highly concentrated consumer and real estate portfolio, with the common thread being Wilson's personal convictions rather than an institutional asset-liability framework.

The most notable holding is 'The Point,' a composite waterfront estate at 3489 Point Grey Road in Vancouver's Kitsilano neighborhood. Assembled through multiple acquisitions, this property is widely reported as the most expensive residential real estate in British Columbia, with a combined acquisition cost exceeding $130 million.

The firm overwhelmingly favors direct and co-investment structures. The team does not market itself as a limited partner in external commingled funds. Publicly visible positions—such as the stake in Amer Sports—are held directly through Wilson's holding company, and the Solve FSHD initiative makes cash-for-equity investments in private biotech companies, functioning like a direct venture investor.

Deal flow appears to originate from Wilson's personal network among global consumer founders and the biotech community. The Amer Sports investment, for example, stemmed from a relationship-driven opportunity when Anta Sports led a buyout consortium. On the FSHD side, Wilson has built deep networks within the research and rare-disease biotech ecosystem, allowing the office to access pre-IPO rounds directly.

Wilson has stated publicly that the bulk of his wealth will not transfer exclusively to his heirs and will instead be allocated to philanthropic causes through vehicles like Solve FSHD. The office does not appear to be building toward a multi-generational family-office franchise in the traditional sense, relying instead on a founder-centric model with a time-bound mission to cure FSHD and deploy the remaining capital.